Year archive

Zhaoke Ophthalmology Limited — 2021 filings

All 48 regulatory filings released by Zhaoke Ophthalmology Limited (6622) in 2021, sourced directly from the official regulator.

48 Filings

2021 Period

2021 filings (48)

Filing	Released	Lang
Voluntary Announcement - Letter of Intent In Relation to Acceleration of the Development of Innovative Clinical Research Programs Regulatory Filings	2021-12-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021 Share Issue/Capital Change	2021-12-02	English
Executive Committee - Terms of Reference Governance Information	2021-11-26	English
Investment Committee - Terms of Reference Governance Information	2021-11-26	English
List of Directors and their role and function Board/Management Information	2021-11-26	English
Establishment of Investment and Executive Committee, and Appointment of Members of the Committee Board/Management Information	2021-11-26	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021 Regulatory Filings	2021-11-01	English
Voluntary Announcement - Full Results of Pivotal Phase III Clinical Trial (COSMO) of Cyclosporine A (CsA) Ophthalmic Gel Released Regulatory Filings	2021-11-01	English
Voluntary Announcement - Appointing PharmaLogic Development, Inc. as Regulatory Consultant for Product Development in North America Board/Management Information	2021-10-25	English
Voluntary Announcement - First Patient Enrolled for Investigator-Initiated Trial of ZKY001 for Neurotrophic Keratitis Regulatory Filings	2021-10-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021 Regulatory Filings	2021-10-04	English
Voluntary Announcement - IND Application of NVK-002 for Phase III Clinical Trial in China Approved by the CDE Regulatory Filings	2021-09-27	English
Interim Report 2021 Regulatory Filings	2021-09-17	English
VOLUNTARY ANNOUNCEMENT - ADAPALENE CLINDAMYCIN HYDROCHLORIDE COMBINATION GEL PASSING THE ON-SITE INSPECTION FOR DRUG REGISTRATION IN CHINA BECOMING THE THIRD GMP INSPECTION THAT THE COMPANY HAS PASSED Regulatory Filings	2021-09-13	English
Voluntary Announcement - Pivotal Phase III Clinical Trial of Levobetaxolol Hydrochloride Eye Drops met its Primary Endpoint Regulatory Filings	2021-09-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021 Share Issue/Capital Change	2021-09-01	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2021 Interim / Quarterly Report	2021-08-18	English
Voluntary Announcement - Pivotal Phase III Clinical Trial of Cyclosporine A (CsA) Ophthalmic Gel (COSMO) met its primary endpoint Regulatory Filings	2021-08-17	English
NOTICE OF BOARD MEETING Regulatory Filings	2021-08-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021 Regulatory Filings	2021-08-04	English
Voluntary Announcement - In Relation to the Approval by The Hainan Provincial Medical Products Administration for the Import of An Urgently Needed Drug, NTC010 Regulatory Filings	2021-08-02	English
Environmental, Social and Governance Report 2020 Regulatory Filings	2021-07-27	English
Voluntary Announcement - IND application of NVK-002 for Phase III Clinical Trial in China accepted for review by the CDE Regulatory Filings	2021-07-15	English
CLARIFICATION ANNOUNCEMENT Regulatory Filings	2021-07-12	English
Voluntary Announcement - Last Patient Completed the Treatment for Phase III Clinical Trial of Cyclosporine A (CsA) Ophthalmic Gel Regulatory Filings	2021-07-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2021 Major Shareholding Notification	2021-07-02	English
Voluntary Announcement - Patent Granted for an Invention of the Company Regulatory Filings	2021-06-21	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2021 Share Issue/Capital Change	2021-06-01	English
Voluntary Announcement - Appointment of Chief Medical Officer Board/Management Information	2021-05-28	English
Voluntary Announcement - Passing the On-Site Inspection for Drug Registration of The National Medical Products Administration and The GMP Compliance Inspection of The Guangdong Medical Products Admini Regulatory Filings	2021-05-24	English
Stabilizing Actions, End of Stabilization Period and Lapse of the Over-Allotment Option Capital/Financing Update	2021-05-21	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2021 Capital/Financing Update	2021-05-04	English
ANNOUNCEMENT 2020 ANNUAL REPORT Report Publication Announcement	2021-04-30	English
Remuneration Committee - Terms of Reference Remuneration Information	2021-04-28	English
Nomination Committee - Terms of Reference Governance Information	2021-04-28	English
Audit Committee - Terms of Reference Governance Information	2021-04-28	English
List of Directors and their Role and Function Board/Management Information	2021-04-28	English
AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2021-04-28	English
ANNOUNCEMENT OF OFFER PRICE AND ALLOTMENT RESULTS Regulatory Filings	2021-04-28	English
CLARIFICATION ANNOUNCEMENT Regulatory Filings	2021-04-28	English
BLUE APPLICATION FORM Capital/Financing Update	2021-04-16	English
GREEN APPLICATION FORM Capital/Financing Update	2021-04-16	English
YELLOW APPLICATION FORM Share Issue/Capital Change	2021-04-16	English
WHITE APPLICATION FORM Capital/Financing Update	2021-04-16	English
GLOBAL OFFERING Capital/Financing Update	2021-04-16	English
GLOBAL OFFERING Capital/Financing Update	2021-04-16	English
PHIP (1st submission) Audit Report / Information FY 2020	2021-04-06	English
PHIP (1st submission) Regulatory Filings	2021-04-06	English